Filana Therapeutics CEO Richard Barry reports $23,322.52 share purchase
FLNA•Filana Therapeutics President and CEO Richard Barry purchased 44,851 common shares at $0.52 each, increasing his indirect beneficial ownership through a trust to 1,955,947 shares.
1. Share purchase
Richard Barry, Filana Therapeutics’ president, CEO and a director, purchased 44,851 common shares at $0.52 per share. The purchase increased his indirect beneficial ownership through a trust to 1,955,947 common shares.




